554 related articles for article (PubMed ID: 17478063)
1. Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
Mirkin S; Archer DF
Maturitas; 2007 Aug; 57(4):338-46. PubMed ID: 17478063
[TBL] [Abstract][Full Text] [Related]
2. Effect of tibolone and its metabolites on vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 mRNA in Ishikawa cells.
Mirkin S; Mahony MC; Archer DF
Menopause; 2004; 11(1):82-8. PubMed ID: 14716187
[TBL] [Abstract][Full Text] [Related]
3. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
Mirkin S; Wong BC; Archer DF
Fertil Steril; 2005 Aug; 84(2):485-91. PubMed ID: 16084894
[TBL] [Abstract][Full Text] [Related]
4. Effects of mifepristone on vascular endothelial growth factor and thrombospondin-1 mRNA in Ishikawa cells: implication for the endometrial effects of mifepristone.
Mirkin S; Archer DF
Contraception; 2004 Oct; 70(4):327-33. PubMed ID: 15451338
[TBL] [Abstract][Full Text] [Related]
5. Tibolone and its metabolites enhance tissue factor and PAI-1 expression in human endometrial stromal cells: Evidence of progestogenic effects.
Schatz F; Kuczynski E; Kloosterboer HJ; Buchwalder L; Tang C; Krikun G; Lockwood CJ
Steroids; 2005 Nov; 70(12):840-5. PubMed ID: 16011840
[TBL] [Abstract][Full Text] [Related]
6. Effects of 17beta-estradiol, progesterone, synthetic progestins, tibolone, and raloxifene on vascular endothelial growth factor and Thrombospondin-1 messenger RNA in breast cancer cells.
Mirkin S; Wong BC; Archer DF
Int J Gynecol Cancer; 2006; 16 Suppl 2():560-3. PubMed ID: 17010073
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of oestrone sulphatase activity by tibolone and its metabolites.
Purohit A; Malini B; Hooymans C; Newman SP
Horm Metab Res; 2002 Jan; 34(1):1-6. PubMed ID: 11832993
[TBL] [Abstract][Full Text] [Related]
8. Effects of tibolone and its metabolites on prolactin and insulin-like growth factor binding protein-1 expression in human endometrial stromal cells.
Guzel E; Buchwalder L; Basar M; Kayisli U; Ocak N; Bozkurt I; Lockwood CJ; Schatz F
Gynecol Endocrinol; 2015 May; 31(5):414-8. PubMed ID: 25856298
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietin-1, angiopoietin-2 and Tie-2 expression in eutopic endometrium in advanced endometriosis.
Hur SE; Lee JY; Moon HS; Chung HW
Mol Hum Reprod; 2006 Jul; 12(7):421-6. PubMed ID: 16723371
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence studies of tibolone in premenopausal women and effects on expression of the tibolone-metabolizing enzyme AKR1C (aldo-keto reductase) family caused by estradiol.
Kang KW; Kim YG
J Clin Pharmacol; 2008 Dec; 48(12):1430-7. PubMed ID: 18832293
[TBL] [Abstract][Full Text] [Related]
11. Regulation of SULT1E1 expression in Ishikawa adenocarcinoma cells by tibolone.
Falany JL; Falany CN
Steroids; 2006 Oct; 71(10):880-5. PubMed ID: 16857224
[TBL] [Abstract][Full Text] [Related]
12. Effects of tibolone on nuclear receptors in human endometrial cells.
Zhang W; Mazella J; Kloosterboer HJ; Tseng L
Am J Obstet Gynecol; 2006 Jul; 195(1):97-102. PubMed ID: 16813748
[TBL] [Abstract][Full Text] [Related]
13. Progestagenic effects of tibolone are target gene-specific in human endometrial cells.
Zhang W; Mazella J; Kloosterboer HJ; Tseng L
J Soc Gynecol Investig; 2006 Sep; 13(6):459-65. PubMed ID: 16879988
[TBL] [Abstract][Full Text] [Related]
14. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma.
Ripley D; Tang XM; Ma C; Chegini N
Gynecol Oncol; 2001 May; 81(2):301-9. PubMed ID: 11330966
[TBL] [Abstract][Full Text] [Related]
15. Involvement of angiopoietin-tie system in bovine follicular development and atresia: messenger RNA expression in theca interna and effect on steroid secretion.
Hayashi KG; Acosta TJ; Tetsuka M; Berisha B; Matsui M; Schams D; Ohtani M; Miyamoto A
Biol Reprod; 2003 Dec; 69(6):2078-84. PubMed ID: 12954734
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
Gong Y; Anzai Y; Murphy LC; Ballejo G; Holinka CF; Gurpide E; Murphy LJ
Cancer Res; 1991 Oct; 51(20):5476-81. PubMed ID: 1833051
[TBL] [Abstract][Full Text] [Related]
17. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of interleukins IL-13 and IL-15 by ovarian steroids, TNF-alpha and TGF-beta in human endometrial epithelial and stromal cells.
Roberts M; Luo X; Chegini N
Mol Hum Reprod; 2005 Oct; 11(10):751-60. PubMed ID: 16254005
[TBL] [Abstract][Full Text] [Related]
19. Progestogenic effects of tibolone on human endometrial cancer cells.
Blok LJ; De Ruiter PE; Kühne EC; Hanekamp EE; Grootegoed JA; Smid-Koopman E; Gielen SC; De Gooyer ME; Kloosterboer HJ; Burger CW
J Clin Endocrinol Metab; 2003 May; 88(5):2327-34. PubMed ID: 12727992
[TBL] [Abstract][Full Text] [Related]
20. Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, progesterone, and 17beta-estradiol on thrombospondin-1 mRNA in Ishikawa cells.
Mirkin S; Archer DF
Fertil Steril; 2004 Jul; 82(1):220-2. PubMed ID: 15237017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]